
Donald Nixon ọ bụ onye na-ede teknọlọjị na onye amamihe dị mkpa. Ọ nụrụ agha nke ya n'ime Kọmputa Sayensi na Enjịnịrị na Duke University, ebe ọ na-amaghịzie nke ụfọdụ n'ime ihe ọhụrụ na agbanwe na teknọlọjị. Ọrụ ya hụrụ ya gaa n'ime ọrụ ndị na-eme ka Symbiotech Corporation, ụlọ ọrụ teknọlọjị mma na-enye ngwágha ihe ọhụrụ. Gafere n'ime afọ, ịmaghịzi Nixon dị mgbakọ n'akụkọ ụzọ nke kọmpaịnị ahụ. N'ime afọ ịri atọ ọrụ ya, ọ debere ihe ndị ọtụtụ dị ka akụkọ ngosi, mkpakọ, na akwụkwọ, na-enye ndị na-anọghịri akụkọ nelu na ịmata dị mkpa n'ime usoro ọhụrụ n'ime teknọlọjị. Nixon na-echere na-enye akụkọ dị mfe na-akpọpụta ihe dị nzuzo ahụ. Aha nke ya n'okwa ọmụma na-eme ka ọ bụ onye a na-ezi na ndị na-akwado na ndị na-anọghịri akụkọ ka-eweere ngozi na eziokwu.